Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Venetoclax in Patients With MDS or AML in Relapse After AHSCT
ClinicalTrials.gov study NCT05226455. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant
ClinicalTrials.gov study NCT00088543. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of AMV564 in Patients With AML
ClinicalTrials.gov study NCT03144245. IPD Sharing: NO. Countries: 1. Publications: 0.
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
ClinicalTrials.gov study NCT07059975. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
ClinicalTrials.gov study NCT06284486. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Clinical Study Assessing Haplo vs. URD in AML
ClinicalTrials.gov study NCT04067180. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation
ClinicalTrials.gov study NCT03121079. IPD Sharing: NO. Countries: 1. Publications: 0.
Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1)
ClinicalTrials.gov study NCT01146977. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Cladribine and Low-Dose Cytarabine (LoDAC) Alternating With Decitabine vs. Hypomethylating Agents (HMA) Plus Venetoclax as Frontline Therapy for AML or High-Grade MDS in Patients Unfit for In
ClinicalTrials.gov study NCT05766514. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients
ClinicalTrials.gov study NCT04015024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML
ClinicalTrials.gov study NCT02326584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00795548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD123 Redirected T Cells for AML in Pediatric Subjects
ClinicalTrials.gov study NCT04678336. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of BTK Inhibitor Overcomes Drug-resistance in Refractory/Relapsed FLT3 Mutant AML
ClinicalTrials.gov study NCT03642236. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
ClinicalTrials.gov study NCT04358393. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01126814. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19
ClinicalTrials.gov study NCT06649227. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients
ClinicalTrials.gov study NCT04087967. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT
ClinicalTrials.gov study NCT05858814. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML
ClinicalTrials.gov study NCT04254640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.